Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Yao

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 24, 2004
Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimenQ Yang, K R Cleary, J C Yao, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2008
A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinomaL C Scott, J C Yao, A B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcomeJ A Ajani, P F Mansfield, C H Crane, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trialM H Kulke, P Ruszniewski, E Van Cutsem, et al.
ESMO Open|February 22, 2025
Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2S Stintzing, J Tabernero, T Satoh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 27, 2013
A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancerJ A Ajani, L Xiao, J A Roth, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 24, 2004
Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimenQ Yang, K R Cleary, J C Yao, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2008
A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinomaL C Scott, J C Yao, A B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcomeJ A Ajani, P F Mansfield, C H Crane, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trialM H Kulke, P Ruszniewski, E Van Cutsem, et al.
ESMO Open|February 22, 2025
Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2S Stintzing, J Tabernero, T Satoh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 27, 2013
A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancerJ A Ajani, L Xiao, J A Roth, et al.
Pageof 3